The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Increase Australias Capacity For Outstanding Health And Medical Research At The Highest Competitive Level Internationally
Funder
National Health and Medical Research Council
Funding Amount
$4,000,000.00
Summary
This Fellowship aims to increase Australia’s capacity for outstanding health and medical research at the highest competitive level internationally by utilising to their full potential the strategically planned population-based research resources I have already established. We have established state of the art protocols for collecting family data, and following up large cohorts of families. We are now in a superb position to rapidly translate genetic findings (ours and others) into clinical and p ....This Fellowship aims to increase Australia’s capacity for outstanding health and medical research at the highest competitive level internationally by utilising to their full potential the strategically planned population-based research resources I have already established. We have established state of the art protocols for collecting family data, and following up large cohorts of families. We are now in a superb position to rapidly translate genetic findings (ours and others) into clinical and public health programs and evaluate their impacts. This Fellowship should encourage high calibre Australian researchers to continue their work in Australia. It will give the resources in terms of people and research funds to develop to its full potential the population resource that I have built up over the last two decades. Funding will strengthen the position of Australian family and twin study resources within the international network so as to further enhance collaborations, knowledge transfer, and permit us to continue to demonstrate leadership. Continued funding of key personnel and the opportunity to recruit the best new talent through offering attractive positions, and funding to conduct our own genetic and molecular analyses rather than handing the material over to others, are essential for us to maintain and enhance the reputation in the highly competitive areas of cancer genetics. That is, we intend to demonstrate that Australia is the leader in the new discipline of MEGA Epidemiology. A major aim of this Fellowship is to use our research findings to “make a difference” to the health and well-being of Australians. This will be achieved by continuing to widen our perspective to include qualitative research techniques in trying to find out what are the issues impacting on the public – and the clinicians and bureaucrats – in decision making around the possibilities and risks being raised by new genetic findings.Read moreRead less
Prof Anderson a clinical neuropsychologist with two broad areas of research: 1) understanding the impact of early childhood brain injury across multiple domains – brain, cognition, social skills, behaviour; and 2) developing and evaluating interventions (child and family-based) to reduce burden following childhood brain injury.
David Whiteman is a medical epidemiologist with a special interest in the causes, diagnosis, prevention and treatment of cancer. His work has focussed on melanoma and skin cancer, and more recently, on cancers of the upper gastro-intestinal tract.
I am a molecular epidemiologist, studying the environmental and genetic causes of cancer, particularly endometrial and breast cancer. I am studying the molecular markers that act as signatures for the environmental and-or genetic aetiology of a given canc